Cargando…

Cutaneous melanoma

Detalles Bibliográficos
Autores principales:	Négrier, S, Fervers, B, Bailly, C, Beckendorf, V, Cupissol, D, Doré, J F, Dorval, T, Garbay, J R, Vilmer, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408839/ https://www.ncbi.nlm.nih.gov/pubmed/11355977 http://dx.doi.org/10.1054/bjoc.2001.1771

Ejemplares similares

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

Mortality from cutaneous melanoma: evidence for contrasting trends between populations
por: Severi, G, et al.
Publicado: (2000)

Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation
por: Thies, A, et al.
Publicado: (2001)

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity
por: Westerdahl, J, et al.
Publicado: (2000)

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis
por: Zerp, S F, et al.
Publicado: (1999)

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma
por: Karjalainen, J M, et al.
Publicado: (2000)

Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors
por: Manne, Sharon L., et al.
Publicado: (2020)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Cancer of the endometrium
por: Brémond, A, et al.
Publicado: (2001)

Telomerase activity in melanoma and non-melanoma skin cancer
por: Parris, C N, et al.
Publicado: (1999)

Chemokine Receptor CXCR4 Is a Novel Marker for the Progression of Cutaneous Malignant Melanomas
por: Toyozawa, Seiko, et al.
Publicado: (2012)

Cutaneous melanoma in Scotland.
por: Gillis, C. R., et al.
Publicado: (1982)

Epithelial tumours of the thymus
por: Ruffié, P, et al.
Publicado: (2001)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

Hodgkins disease
por: Ferme, C, et al.
Publicado: (2001)

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)

Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism.
por: Jacubovich, R., et al.
Publicado: (1985)

Thrombospondin modulates melanoma--platelet interactions and melanoma tumour cell growth in vivo.
por: Boukerche, H., et al.
Publicado: (1995)

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
por: Cameron, D A, et al.
Publicado: (2001)

Osteosarcoma
por: Philip, T, et al.
Publicado: (2001)

Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts)
por: Langezaal, S M, et al.
Publicado: (2001)

Oral contraceptive use and risk of melanoma in premenopausal women
por: Feskanich, D, et al.
Publicado: (1999)

High tPA-expression in primary melanoma of the limb correlates with good prognosis
por: Ferrier, C M, et al.
Publicado: (2000)

Cutaneous malignant melanoma in Northern Ireland.
por: Pedlow, P. J., et al.
Publicado: (1997)

Mutation testing in melanoma families: INK4A, CDK4 and INK4D
por: Newton Bishop, J A, et al.
Publicado: (1999)

Investigation of female survival benefit in metastatic melanoma
por: Richardson, B, et al.
Publicado: (1999)

Selenium for the Prevention of Cutaneous Melanoma
por: Cassidy, Pamela B., et al.
Publicado: (2013)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas
por: Edmunds, S C, et al.
Publicado: (2003)

Ovarian cancer
por: Kerbrat, P, et al.
Publicado: (2001)

SOR: project methodology
por: Fervers, B, et al.
Publicado: (2001)

Carcinoma of the cervix
por: Resbeut, M, et al.
Publicado: (2001)

Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization
por: Hipfel, R, et al.
Publicado: (2000)

Feasibility of targeted early detection for melanoma: a population-based screening study
por: Melia, J, et al.
Publicado: (2000)

Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
por: Sisley, K, et al.
Publicado: (2000)

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood
por: Vries, T J de, et al.
Publicado: (1999)

Mechanisms of local immunosuppression in cutaneous melanoma
por: Polak, M E, et al.
Publicado: (2007)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo
por: Guba, M, et al.
Publicado: (2000)

Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial
por: Ravaud, A, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_qade57ubrb8ac1k1vojj62d8pq